Real-World T790M Mutation Frequency and Impact of Rebiopsy in Patients With EGFR-Mutated Advanced Non-Small Cell Lung Cancer-Reference-Cited by-同舟云学术

Real-World T790M Mutation Frequency and Impact of Rebiopsy in Patients With EGFR-Mutated Advanced Non-Small Cell Lung Cancer

Published:2020-12-17 Issue: Volume: Page:
ISSN:2168-8184
Container-title:Cureus
language:en
Short-container-title:

Author:

Pereira Isabel,Gaspar Cátia,Pina Marta,Azevedo Isabel,Rodrigues Ana

Publisher

Cureus, Inc.

Subject

Aerospace Engineering

Reference30 articles.

1. Global cancer statistics. 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray F;CA Cancer J Clin,2018

2. The Global Cancer Observatory. (2018). Accessed. April 11, 2020: https://gco.iarc.fr/today/data/factsheets/populations/620-portugal-fact-sheets.pdf.

3. Twenty-two years of phase III trials for patients with advanced non-small-cell lung cancer: sobering results;Breathnach OS;J Clin Oncol,2001

4. Updated analysis of global epidemiology of EGFR mutation in advanced non-small cell lung cancer;Werutsky G;J Thorac Oncol,2016

5. Overview of current systemic management of EGFR-mutant NSCLC;Hsu WH;Ann Oncol,2018

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current status and breakthroughs in treating advanced non-small cell lung cancer with EGFR exon 20 insertion mutations;Frontiers in Immunology;2024-05-07

2. Overview of Molecular Diagnostics in Irish Clinical Oncology;HRB Open Research;2024-03-26

3. Potential of Targeting TDO2 as the Lung Adenocarcinoma Treatment;Journal of Proteome Research;2024-02-29

4. Patient Characteristics, Testing and Treatment Patterns, and Outcomes in EGFR-Mutated Advanced Non-Small Cell Lung Cancer: A Multinational, Real-World Study;Advances in Therapy;2023-05-23

5. Liquid Biopsy in EGFR-Mutated Advanced NSCLC from T790M to MET Amplification: Clinical Implications and Possibilities in the Resistance Setting;Journal of Molecular Pathology;2023-04-30